Adiponectin in children on peritoneal dialysis: relationship to insulin resistance and nutritional status

Mariana Kamariski1, Mónica Biscardi, Laura Cestino

  • 1Area de Fisiopatología, Departamento de Patología, Facultad de Ciencias Médicas, Universidad Nacional de Cuyo, Mendoza, Argentina.

Insights

In pediatric peritoneal dialysis (PD) patients, higher adiponectin levels correlate with lower body mass index (BMI) and body fat, suggesting a role in clinical wasting. Resistin levels did not differ significantly among groups.

Area of Science:

  • Pediatric Nephrology
  • Endocrinology
  • Nutritional Science

Background:

  • Peritoneal dialysis (PD) in children can impact nutritional status and metabolic health.
  • Adiponectin and resistin are adipokines with known roles in metabolism and inflammation, but their specific associations in pediatric PD patients are not well-defined.

Purpose of the Study:

  • To investigate the relationship between serum adiponectin and resistin levels and insulin resistance (IR) and anthropometric parameters in children undergoing PD.
  • To compare these parameters between PD patients, chronic kidney disease (CKD) patients, and healthy controls.

Main Methods:

  • Oral glucose tolerance test to measure glucose and insulin.
  • Enzyme-linked immunosorbent assay (ELISA) for adiponectin and resistin.
  • Radioimmunoassay (RIA) for insulin.

Main Results:

  • PD patients exhibited significantly higher adiponectin levels and lower body mass index (BMI) and body fat content compared to controls.
  • CKD patients showed higher insulin resistance (IR) markers (HOMA-IR, fasting and 2-hour insulin) than controls and PD patients.
  • Adiponectin was inversely associated with BMI, weight, height z-score, and body fat, but not directly with IR parameters. Both adiponectin and resistin correlated negatively with glomerular filtration rate.

Conclusions:

  • Adiponectin may play a role in the clinical wasting observed in pediatric PD patients, as indicated by its association with reduced anthropometric parameters.
  • Further research is warranted to elucidate the precise mechanisms linking adiponectin to nutritional status in this population.
Abstract

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...